N

Intellia Therapeutics, Inc.

NTLA
—
—
/100 Overall
Calculating score…
Running full analysis
Ready to value this company?
Run a full DCF model with Monte Carlo simulation.
Run DCF Valuation →
📊 Key Metrics
Loading full analysis…
REVENUE TTM
$66.1M
32.6% CAGR
FCF TTM
-$503.4M
-761.7% margin
Running full 6-factor analysis…